1. Home
  2. ASMB vs OWLS Comparison

ASMB vs OWLS Comparison

Compare ASMB & OWLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$20.29

Market Cap

512.1M

Sector

Health Care

ML Signal

HOLD

Logo OBOOK Holdings Inc.

OWLS

OBOOK Holdings Inc.

HOLD

Current Price

$2.79

Market Cap

469.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
OWLS
Founded
2005
2010
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
512.1M
469.9M
IPO Year
2010
2024

Fundamental Metrics

Financial Performance
Metric
ASMB
OWLS
Price
$20.29
$2.79
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $52.00
N/A
AVG Volume (30 Days)
★ 202.1K
20.4K
Earning Date
11-09-2026
08-21-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 91.78
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.77
Revenue Next Year
N/A
$480.00
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.94
$3.96
52 Week High
$39.71
$13.89

Technical Indicators

Market Signals
Indicator
ASMB
OWLS
Relative Strength Index (RSI) 31.31 9.09
Support Level N/A N/A
Resistance Level $30.36 $5.76
Average True Range (ATR) 1.10 0.33
MACD 0.10 -0.23
Stochastic Oscillator 7.07 0.37

Price Performance

Historical Comparison
ASMB
OWLS

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About OWLS OBOOK Holdings Inc.

OBOOK Holdings Inc operate as a blockchain-powered technology company. It provides solutions across three main business segments: payments, hospitality, and e-commerce, serving businesses and individuals whose commercial activities involve cross-border transactions. The company has five reportable segments: Payment service provides payment solutions to customers, including payment gateway services and payout services; Hospitality-related software services provide the subscription to the OwlNest PMS and the add-on room fee collection services offered to the clients using OwlNest; Hospitality-related platform services that provide an OTA platform and offline platform services offering accommodation services; The E-commerce platform engages in selling products online; and Other services.

Share on Social Networks: